Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme

Journal Article · Fri Oct 30 00:00:00 EDT 2015 · European Journal of Medicinal Chemistry - Chimica Therapeutica

DOI:https://doi.org/10.1016/j.ejmech.2014.12.005· OSTI ID:1208682

Charton, Julie ^[1]; Gauriot, Marion ^[1]; Totobenazara, Jane ^[1]; Hennuyer, Nathalie ^[2]; Dumont, Julie ^[1]; Bosc, Damien ^[1]; Marechal, Xavier ^[1]; Elbakali, Jamal ^[1]; Herledan, Adrien ^[1]; Wen, Xiaoan ^[1]; Ronco, Cyril ^[1]; Gras-Masse, Helene ^[1]; Heninot, Antoine ^[1]; Pottiez, Virginie ^[1]; Landry, Valerie ^[1]; Staels, Bart ^[2]; Liang, Wenguang G. ^[3]; Leroux, Florence ^[1]; Tang, Wei -Jen ^[3]; Deprez, Benoit ^[1] ; Deprez-Poulain, Rebecca ^[1]

---

1. Biostructures and Drug Discovery, Lille (France); Institut Pasteur de Lille, Lille (France); PRIM, Lille (France); CDithem Platform/IGM, Paris (France)
2. Institut Pasteur de Lille, Lille (France); INSERM U1011 Nuclear Receptors, Lille (France)
3. The Univ. of Chicago, Chicago, IL (United States)

Insulin degrading enzyme (IDE) is a zinc metalloprotease that degrades small amyloid peptides such as amyloid-â and insulin. So far the dearth of IDE-specific pharmacological inhibitors impacts the understanding of its role in the physiopathology of Alzheimer's disease, amyloid-â clearance, and its validation as a potential therapeutic target. Hit 1 was previously discovered by high-throughput screening. Here we describe the structure-activity study, that required the synthesis of 48 analogues. We found that while the carboxylic acid, the imidazole and the tertiary amine were critical for activity, the methyl ester was successfully optimized to an amide or a 1,2,4-oxadiazole. Along with improving their activity, compounds were optimized for solubility, lipophilicity and stability in plasma and microsomes. The docking or co-crystallization of some compounds at the exosite or the catalytic site of IDE provided the structural basis for IDE inhibition. The pharmacokinetic properties of best compounds 44 and 46 were measured in vivo. As a result, 44 (BDM43079) and its methyl ester precursor 48 (BDM43124) are useful chemical probes for the exploration of IDE's role.

• Research Organization: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
• Sponsoring Organization: FOREIGN
• OSTI ID: 1208682
• Journal Information: European Journal of Medicinal Chemistry - Chimica Therapeutica, Journal Name: European Journal of Medicinal Chemistry - Chimica Therapeutica Journal Issue: C Vol. 90; ISSN 0223-5234
• Country of Publication: United States
• Language: ENGLISH